Brought to you by 
Device company Veniti raises $25mm in Series D from Boston Scientific
13 Aug 2018
Executive Summary
Veniti Inc. (devices for treatment of deep venous disease) raised $25mm in its Series D round from Boston Scientific Corp. The company will use the proceeds to complete its VIRTUS trial (using the Vici Venous Stent System to address chronic venous disorder, venous outflow obstruction, and symptomatic venous outflow obstruction of the iliofemoral vein); for a regulatory filing for the system; and to expand product development and commercial operations.
Deal Industry
- Medical Devices
-
Medical Devices
- Implantable Devices
-
Surgical Equipment & Devices
- Minimally or Less Invasive
Deal Status
- Final
Deal Type
-
Financing
- Venture Financing
Already a Biomedtracker subscriber?
You have access to the full deal record through your subscription
Want to become a subscriber?
Subscribers get more deal details, updates, deal financials and deal products.
Questions?
Questions?
Please contact Sales at: (212) 520-2765 or email [email protected]
Related Companies
You must sign in to use this functionality
Authentication.SignIn.HeadSignInHeader
Device company Veniti raises $25mm in Series D from Boston Scientific
Email Deal
All set! This article has been sent to my@email.address.
All fields are required. For multiple recipients, separate email addresses with a semicolon.
DCD.EmailPopout.Notice